James Hattersley
Corporate Officer/Principal bei PALATIN TECHNOLOGIES, INC.
Profil
James E.
Hattersley is currently a Director at Temple Therapeutics BV and a Senior Vice President-Business Development at Palatin Technologies, Inc. He was previously a Vice President-Business Development at Nektar Therapeutics from 2014 to 2015, a Vice President-Business Development at Antares Pharma, Inc., and a Vice President-Business Development at Sun Pharmaceutical Industries, Inc. from 2008 to 2014.
He also served as a Senior Vice President-Business Development at Adherium Ltd.
Mr. Hattersley received his undergraduate degree from the University of California and his graduate degree from The University of Chicago Booth School of Business.
Aktive Positionen von James Hattersley
| Unternehmen | Position | Beginn |
|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Corporate Officer/Principal | 28.06.2021 |
Temple Therapeutics BV
 Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Director/Board Member | - |
Ehemalige bekannte Positionen von James Hattersley
| Unternehmen | Position | Ende |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01.12.2015 |
Sun Pharmaceutical Industries, Inc.
 Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Sun Pharmaceutical Industries, Inc. provides pharmaceutical products. Its products include petrochemical, drugs, vaccines and fertilizers. The company is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01.05.2014 |
| ADHERIUM LIMITED | Corporate Officer/Principal | - |
| ANTARES PHARMA, INC. | Corporate Officer/Principal | - |
Ausbildung von James Hattersley
| University of California | Undergraduate Degree |
| The University of Chicago Booth School of Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| ADHERIUM LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Sun Pharmaceutical Industries, Inc. provides pharmaceutical products. Its products include petrochemical, drugs, vaccines and fertilizers. The company is headquartered in Cranbury, NJ. | Health Technology |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Health Technology |
